Navigation Links
Vermillion Sharpens Focus and Streamlines Operations in 2012
Date:1/4/2012

ding the risk that its products will not be competitive with products offered by other companies, or that users will not be entitled to receive adequate reimbursement for its products from third party payors such as private insurance companies and government insurance plans; (5) uncertainty that Vermillion will successfully license or otherwise successfully partner with third parties to commercialize its future products; (6) uncertainty whether the trading in Vermillion's stock will become significantly less liquid; and (7) other factors that might be described from time to time in Vermillion's filings with the Securities and Exchange Commission. All information in this press release is as of the date of this report, and Vermillion expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Vermillion's expectations or any change in events, conditions or circumstances on which any such statement is based, unless required by law.

This release should be read in conjunction with the consolidated financial statements and notes thereto included in our most recent reports on Form 10-K and Form 10-Q. Copies are available through the SEC's Electronic Data Gathering Analysis and Retrieval system (EDGAR) at www.sec.gov.

 

 

 


'/>"/>
SOURCE Vermillion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Vermillion Receives Notice of Allowance for 5th Biomarker Patent Related to Peripheral Artery Disease
2. Vermillion Reports Results for the Second Quarter 2011
3. Vermillion Announces Notice of Allowance for Peripheral Artery Disease (PAD) Patent
4. Vermillion Announces Joining Russell Microcap® Index
5. Vermillion Announces Notice of Allowance for Alzheimer Patent
6. Vermillion Announces the Appointment of Bruce Huebner to its Board of Directors
7. Vermillion to Host Conference Call to Present Company Update and Review Financial Results for the First Quarter 2011
8. Stephens Initiates Coverage on Vermillion
9. Vermillion Announces Notice of Allowance of Patent for Breast Cancer Biomarkers
10. Vermillion Announces Issuance of European Patent
11. Vermillion to Attend Society of Gynecologic Oncologists Meeting March 15-19
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015 GOJO, inventors of ... commitment to antibiotic stewardship at the White House Forum.  ... animal health organizations and stakeholders at the White House ... to slow the emergence of antibiotic-resistant bacteria, detect resistant ... prevent the spread of resistant infections. "A ...
(Date:6/1/2015)... (PRWEB) June 02, 2015 Chosen ... health care, Jack Uldrich has been selected as ... New York today. He will deliver his keynote: ... Uldrich has delivered presentations to the American Medical ... Audiology and Neurology, Alcetel-Lucent/Verizon Forum on Wireless Healthcare, ...
(Date:6/1/2015)... 2015 GenomeDx Biosciences today announced ... successfully classified various subtypes of bladder cancer ... biomarkers, including one type associated with resistance ... signature has potential as a tool to ... patients with muscle-invasive bladder cancers (MIBC). The ...
(Date:6/1/2015)... 1, 2015  The Val Skinner Foundation is partnering ... curriculum for high school students focused on cancer genetics. ... annual LIFE Event (LPGA Pros in the Fight to ... in West Caldwell, N.J. ... raised more than $500,000 on Monday, bringing the foundation,s ...
Breaking Biology Technology:GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 2GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 3GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 4Futurist Jack Uldrich to Address the Future of Pharmaceuticals 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 4Val Skinner Foundation Announces Partnership With Discovery Education 2
... Sept. 29 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE:,WX), a leading ... with operations in China and the United,States, announced today ... venture,with Covance Inc. WuXi will maintain its original plan ... facility in Suzhou, China which is,slated to open in ...
... Sept. 29 Cell Therapeutics, Inc.,("CTI" or the "Company") ... that,a single institutional investor shall purchase, for $14.2 million, ... conversion price of,$1.27 per share. The transaction is the ... (as amended on September 26, 2008) under which,the investor ...
... SYDNEY, Australia, Sept. 26 A non-invasive blood,monitoring ... to monitor patients,has won the 2008 Kerrin Rennie ... presented to Masimo Corporation on 24 September at ... Sydney., The Radical-7 Pulse CO-Oximeter from Masimo ...
Cached Biology Technology:WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China 2Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes 2Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes 3No Blood Needed Thanks to Innovative Medical Technology 2
(Date:4/27/2015)... ATLANTA , April 27, 2015  For more ... and trade show has been the premier worldwide event ... Systems 2015 is a must-attend event for any local, ... insight into the emerging commercial markets and current applications ... and innovations of this projected $48 billion industry, and ...
(Date:4/21/2015)... Canada , April 21, 2015 ... and evolving government policies are boosting access control systems ... According to a recently published report by ... Opportunities, 2020 ", the access control systems market in ... nearly USD1.2 billion by 2020.The access control systems market ...
(Date:4/17/2015)... BURNABY, Canada , April 17, 2015 /PRNewswire/ ... projects, growing security concerns, and technological advancement to ... Arabia until 2020   ... " Saudi Arabia Biometric Systems Market Forecast &  Opportunities, 2020 ", biometric ... is projected to register growth at CAGR ...
Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3
... SAN DIEGO, Calif. (August 28, 2013) In the United ... but many go undiagnosed because for some athletes, the fear ... and there is no objective test available to accurately diagnose ... State University have set out to change that. , ...
... August 27, 2013 A recently reported blood test ... enable more timely therapeutic intervention in transplant patients and ... by scientists at the University Medical Center Gttingen and ... uses Bio-Rad Laboratories, Droplet Digital PCR (ddPCR) ...
... (Aug. 27, 2013) Fifteen years ago, a hematologist ... generations of an East Texas family suffered from a moderately ... would do elective surgery because they bled too much after ... Medical Genetics at The University of Texas Health Science Center ...
Cached Biology News:Combating concussions 2Combating concussions 3Researchers develop rapid, cost-effective early detection method for organ transplant injury 2Researchers develop rapid, cost-effective early detection method for organ transplant injury 3UTHealth, Swedish researchers uncover mystery in blot clotting disorder 2
... Cytomics FC 500 Series is ... with the most advanced technologies ... delivers flexible testing, powerful software ... that help researchers optimize their ...
... 250 g monoclonal antibody irreversibly crosslinked to ... g of PDH complex from heart mitochondria. ... heart mitochondria for control immunocapture. ,The pyruvate ... of PDH from small amounts of tissue. ...
... be superior to transfection in some applications. ... PULSin you can study lethal proteins and ... proteins in cells. Likewise, delivery of blocking ... RNA interference experiments. ,With PULSin you ...
... may be superior to transfection in some ... with PULSin you can study lethal proteins ... of proteins in cells. Likewise, delivery of ... traditional RNA interference experiments. ,With PULSin ...
Biology Products: